Ainos, Inc. $(AIMD)$ released its financial results for the second quarter of 2025, highlighting a significant increase in revenue driven by its AI Nose platform. The company's transition from research and development to revenue-generating deployment in Japan's senior care sector has contributed to this growth. The first half of 2025 marked a strategic inflection point, with Ainos achieving its first senior care revenue and forming new strategic partnerships. The company reported improved gross margins and achieved gross profitability in both Q2 and the first half of 2025. Ainos also managed to narrow its operating cash outflows by 26% year over year, reflecting disciplined capital management. The recent 1-for-5 reverse stock split was completed to regain Nasdaq compliance and strengthen the company's capital structure, thus positioning Ainos to attract institutional investors. Ainos secured a significant three-year subscription-based order valued at $2.1 million with ASE Technology Holding Co., Ltd., marking the first commercial success of its AI Nose platform in the semiconductor manufacturing sector. Looking forward, Ainos plans to continue advancing its strategic priorities and drive long-term growth, backed by its solid financial strategy and expanding commercial traction in various sectors such as robotics, semiconductors, and smart manufacturing.